MaxCyte expands capacity by relocating to new HQ in Maryland

Sep. 21, 2022 9:26 AM ETMaxCyte, Inc. (MXCT)By: Ravikash, SA News Editor2 Comments

Modern Medicine Research Laboratory: Diverse Team of Multi-Ethnic Young Scientists Passes Samples in Petri Dish. Advanced Lab with High-Tech Equipment, Microbiology Researchers Design, Develop Drugs


  • MaxCyte (NASDAQ:MXCT) said it relocated its headquarters to Key West Avenue in Rockville, Maryland, within Maryland's I-270 Biotech Corridor.
  • The new 67K square-foot facility increases MaxCyte's in-house manufacturing capacity and research and process development lab space, the company said in a Sept. 21 press release.
  • MXCT -2.09% to 6.10 premarket Sept. 21

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.